Hyperprogressive disease of non-small-cell lung adenocarcinoma under immune-checkpoint inhibitors: A new response pattern to be recognized by the radiologist
2019 ◽
Vol 100
(5)
◽
pp. 313-315
◽
2021 ◽
Vol 27
◽
pp. 100330
◽